<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>00871nam a22001697a 4500</leader>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="c">Riphah International University</subfield>
  </datafield>
  <datafield tag="082" ind1=" " ind2=" ">
    <subfield code="a">615.1</subfield>
    <subfield code="b">RAS</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Rashid Mahmood (12064)</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Development of chewable tablet formulations for cetirizine HCI, levocetirizine HCI, loratadine &amp; domperidone using polysucralose as sweetening agent </subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">Lahore</subfield>
    <subfield code="b">(Unpublished)</subfield>
    <subfield code="c">2016</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">viii, 87 p.</subfield>
    <subfield code="b">: ill. (col.) </subfield>
    <subfield code="c">; 29 cm.</subfield>
    <subfield code="e">+ CD</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">Submitted in fulfillment of the requirements for the degree of  Master of Philosophy to the Riphah institute of Pharmaceutical Sciences</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">Includes bibliographical references </subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">Thesis supervisor: Dr. Muhammad Farhan Sohail </subfield>
  </datafield>
  <datafield tag="546" ind1=" " ind2=" ">
    <subfield code="a">English</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2=" ">
    <subfield code="a"> Pharmaceutical Sciences</subfield>
    <subfield code="a">Pharmacology</subfield>
    <subfield code="v">Chewable tablet</subfield>
    <subfield code="v">Drug formulation </subfield>
    <subfield code="v">Cetirizine HCI</subfield>
    <subfield code="v">Domperidone </subfield>
    <subfield code="v">Loratadine </subfield>
    <subfield code="v">RIPS</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="4">0</subfield>
    <subfield code="7">1</subfield>
    <subfield code="a">LCC</subfield>
    <subfield code="b">LCC</subfield>
    <subfield code="d">2018-12-31</subfield>
    <subfield code="e">Riphah international university</subfield>
    <subfield code="l">0</subfield>
    <subfield code="o">615.1 RAS</subfield>
    <subfield code="p">38571</subfield>
    <subfield code="r">2018-12-31 00:00:00</subfield>
    <subfield code="t">1</subfield>
    <subfield code="y">TH</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">23909</subfield>
    <subfield code="d">23909</subfield>
  </datafield>
</record>
